Logo image of NUS.MI

NUSCO SPA (NUS.MI) Stock Fundamental Analysis

BIT:NUS - Euronext Milan - IT0005453110 - Common Stock - Currency: EUR

1.01  -0.06 (-5.61%)

Fundamental Rating

4

Taking everything into account, NUS scores 4 out of 10 in our fundamental rating. NUS was compared to 20 industry peers in the Building Products industry. NUS has only an average score on both its financial health and profitability. NUS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: NUS reported negative operating cash flow in multiple years.
NUS.MI Yearly Net Income VS EBIT VS OCF VS FCFNUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

NUS's Return On Assets of 4.65% is fine compared to the rest of the industry. NUS outperforms 71.43% of its industry peers.
The Return On Equity of NUS (10.07%) is comparable to the rest of the industry.
NUS has a better Return On Invested Capital (9.38%) than 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NUS is below the industry average of 9.15%.
The 3 year average ROIC (5.20%) for NUS is below the current ROIC(9.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.65%
ROE 10.07%
ROIC 9.38%
ROA(3y)2.06%
ROA(5y)1.21%
ROE(3y)4.83%
ROE(5y)2.67%
ROIC(3y)5.2%
ROIC(5y)4.53%
NUS.MI Yearly ROA, ROE, ROICNUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

With a Profit Margin value of 4.70%, NUS perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
The Operating Margin of NUS (9.15%) is better than 61.90% of its industry peers.
In the last couple of years the Operating Margin of NUS has grown nicely.
NUS's Gross Margin of 31.13% is on the low side compared to the rest of the industry. NUS is outperformed by 66.67% of its industry peers.
NUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.15%
PM (TTM) 4.7%
GM 31.13%
OM growth 3Y75.38%
OM growth 5Y49.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.34%
GM growth 5Y-0.9%
NUS.MI Yearly Profit, Operating, Gross MarginsNUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NUS is still creating some value.
Compared to 1 year ago, NUS has less shares outstanding
NUS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NUS has a worse debt to assets ratio.
NUS.MI Yearly Shares OutstandingNUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
NUS.MI Yearly Total Debt VS Total AssetsNUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.06 indicates that NUS is not a great score, but indicates only limited risk for bankruptcy at the moment.
NUS has a worse Altman-Z score (2.06) than 61.90% of its industry peers.
The Debt to FCF ratio of NUS is 43.85, which is on the high side as it means it would take NUS, 43.85 years of fcf income to pay off all of its debts.
NUS's Debt to FCF ratio of 43.85 is on the low side compared to the rest of the industry. NUS is outperformed by 76.19% of its industry peers.
NUS has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
NUS has a better Debt to Equity ratio (0.23) than 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 43.85
Altman-Z 2.06
ROIC/WACC1.4
WACC6.68%
NUS.MI Yearly LT Debt VS Equity VS FCFNUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

2.3 Liquidity

A Current Ratio of 1.76 indicates that NUS should not have too much problems paying its short term obligations.
The Current ratio of NUS (1.76) is better than 71.43% of its industry peers.
NUS has a Quick Ratio of 1.31. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS's Quick ratio of 1.31 is fine compared to the rest of the industry. NUS outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.31
NUS.MI Yearly Current Assets VS Current LiabilitesNUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.49%, which is quite impressive.
Looking at the last year, NUS shows a quite strong growth in Revenue. The Revenue has grown by 18.37% in the last year.
Measured over the past years, NUS shows a very strong growth in Revenue. The Revenue has been growing by 25.88% on average per year.
EPS 1Y (TTM)110.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.98%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y54.41%
Revenue growth 5Y25.88%
Sales Q2Q%7.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUS.MI Yearly Revenue VS EstimatesNUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.21 indicates a rather cheap valuation of NUS.
100.00% of the companies in the same industry are more expensive than NUS, based on the Price/Earnings ratio.
NUS is valuated cheaply when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.21
Fwd PE N/A
NUS.MI Price Earnings VS Forward Price EarningsNUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 80.95% of the companies listed in the same industry.
76.19% of the companies in the same industry are cheaper than NUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 79.83
EV/EBITDA 4.04
NUS.MI Per share dataNUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUSCO SPA

BIT:NUS (6/12/2025, 7:00:00 PM)

1.01

-0.06 (-5.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.15M
Analysts80
Price Target2.24 (121.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.21
Fwd PE N/A
P/S 0.34
P/FCF 79.83
P/OCF 24.85
P/B 0.74
P/tB 0.94
EV/EBITDA 4.04
EPS(TTM)0.14
EY13.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.25%
OCF(TTM)0.04
OCFY4.02%
SpS2.94
BVpS1.37
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 10.07%
ROCE 15.43%
ROIC 9.38%
ROICexc 10.02%
ROICexgc 12.22%
OM 9.15%
PM (TTM) 4.7%
GM 31.13%
FCFM 0.43%
ROA(3y)2.06%
ROA(5y)1.21%
ROE(3y)4.83%
ROE(5y)2.67%
ROIC(3y)5.2%
ROIC(5y)4.53%
ROICexc(3y)5.63%
ROICexc(5y)4.83%
ROICexgc(3y)7.05%
ROICexgc(5y)5.8%
ROCE(3y)8.55%
ROCE(5y)7.45%
ROICexcg growth 3Y120.86%
ROICexcg growth 5Y49.83%
ROICexc growth 3Y118.36%
ROICexc growth 5Y48.69%
OM growth 3Y75.38%
OM growth 5Y49.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.34%
GM growth 5Y-0.9%
F-Score8
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 43.85
Debt/EBITDA 0.86
Cap/Depr 30.84%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 11.31%
Profit Quality 9.16%
Current Ratio 1.76
Quick Ratio 1.31
Altman-Z 2.06
F-Score8
WACC6.68%
ROIC/WACC1.4
Cap/Depr(3y)720.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)25.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.37%
Revenue growth 3Y54.41%
Revenue growth 5Y25.88%
Sales Q2Q%7.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y77.89%
EBIT growth 3Y170.8%
EBIT growth 5Y87.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.18%
FCF growth 3YN/A
FCF growth 5Y-37.19%
OCF growth 1Y140.15%
OCF growth 3Y-6.63%
OCF growth 5Y-29.6%